Publikationen von Odette Wegwarth

Rebitschek, F. G., Pashayan, N., Widschwendter, M., & Wegwarth, O. (2019). Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries. PLoS ONE, 14(6), Article e0218188. https://doi.org/10.1371/journal.pone.0218188

Rebitschek, F. G., Reisel, D., Lein, I., & Wegwarth, O. (2019). Epigenetic risk assessment of female cancers: Women's information needs and attitudes. Public Health Genomics, 22(1-2), 46–57. https://doi.org/10.1159/000501975

Wegwarth, O., Pashayan, N., Widschwendter, M., & Rebitschek, F. G. (2019). Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: A cross-sectional online survey. BMC Public Health, 19, Article 667. https://doi.org/10.1186/s12889-019-6994-8

Wegwarth, O., Widschwendter, M., Cibula, D., Sundström, K., Portuesi, R., Lein, I., Rebitschek, F. G., & FORECEE (4C) Consortium. (2018). What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries. BMJ Open, 8, Article e023789. https://doi.org/10.1136/bmjopen-2018-023789

Widschwendter, M., Jones, A., Evans, I., Reisel, D., Dillner, J., Sundström, K., Steyerberg, E. W., Vergouwe, Y., Wegwarth, O., Rebitschek, F. G., Siebert, U., Sroczynski, G., de Beaufort, I. D., Bolt, I., Cibula, D., Zikan, M., Bjørge, L., Colombo, N., Harbeck, N., Dudbridge, F., Tasse, A.-M., Knoppers, B. M., Joly, Y., Teschendorff, A. E., Pashayan, N., & the FORECEE (4C) Consortium. (2018). Epigenome-based cancer risk prediction: Rationale, opportunities and challenges. Nature Reviews Clinical Oncology, 15(5), 292–309. https://doi.org/10.1038/nrclinonc.2018.30

McDowell, M., Rebitschek, F. G., Gigerenzer, G., & Wegwarth, O. (2016). A simple tool for communicating the benefits and harms of health interventions: A guide for creating a fact box. MDM Policy & Practice, 1, Article 2381468316665365. https://doi.org/10.1177/2381468316665365

Wegwarth, O. (2024). Exkurs: Eine Frage des Vertrauens. Transparenz in der Gesundheitskommunikation. In C. Straub (Ed.), Transparenz im Gesundheitswesen: Vertrauen. Wissen. Partizipation. (pp. 31–36). Medizinisch Wissenschaftliche Verlagsgesellschaft.

Wegwarth, O., & Rebitschek, F. G. (2021). Kritisches Denken. In D. Matusiewicz & J. A. Werner (Eds.), Future Skills in Medizin und Gesundheit: Kompetenzen, Stärken, Menschen (pp. 141–146). Medizinisch Wissenschaftliche Verlagsgesellschaft.

Rebitschek, F., & Wegwarth, O. (2017). Risikokommunikation beim (epi-)genetischen prädiktiven Testen auf weibliche Krebsarten. In K. M. Einhäupl (Ed.), Medizin 4.0: Zur Zukunft der Medizin in der digitalisierten Welt. IV. Interdisziplinärer Kongress Junge Wissenschaft und Praxis, 1.-2. Juni 2016, im Langenbeck-Virchow-Haus, Berlin (pp. 117–123). Hanns Martin Schleyer-Stiftung.

Gradwohl, N., Giese, H., Wormer, H., & Wegwarth, O. (2025). Nontransparent health risk communication during the COVID-19 pandemic in 3 German news outlets. PsyArXiv, July 29, 2025. https://doi.org/10.31234/osf.io/9d53q_v1